Media-OutReach Newswire Daphne Announces 2024 Annual Results Revenue and Profit Attributable to Shareholders up 23% and 71% Respectively
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 2.